About Us
Meet the Team
Conditions & Procedures
Patient Center
- Patient Stories
- Patient Resources
Appointments & Referrals
- Request an Appointment
- Refer a Patient
- Location & Directions
Education & Training
Residencies
- Vascular Surgery Integrated Residency (ACGME)
Fellowships
- Fellowship History
- Vascular Surgery Fellowship (ACGME)
- Limb Preservation Fellowship (NON-ACGME)
Clinical Fellows
- Vascular Surgery
- Limb Preservation
Medical Students
- Vascular Surgery Interest Group (VSIG)
The Wylie Society
- About the Wylie Society
Research
Clinical Research
- Clinical Trials
- Clinical Research Team
Vascular Surgery Labs
- Atherosclerosis Research Lab
- Conte Lab
- Wang Lab
Wylie Society
Symposium
News & Events
Shant Vartanian, M.D.
- Associate Professor of Surgery
- Division of Vascular & Endovascular Surgery
- Service Chief of Vascular Surgery at Zuckerberg San Francisco General Hospital
Contact Information
Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
Education
1994-98, Stanford University, B.Sc. (HON) Biological Sciences
1999-03, Saint Louis University, Doctor of Medicine
Residencies
- 2003-04, University of California, San Francisco, Intern, General Surgery
- 2004-09, University of California, San Francisco, Resident, General Surgery
- 2005-07, University of California, San Francisco, Post-Doctoral Research Fellow, Laboratory for Accelerated Vascular Research
- 2009-10, University of California, San Francisco, Chief Resident, General Surgery
Clinical Expertise
- Abdominal Aortic Aneurysm
- Aortic Dissection
- Carotid Artery Disease
- Complex Limb Revascularization
- Critical Limb Ischemia
- Diabetic Vascular Disease
- Dialysis Access
- Endovascular Aneurysm Repair
- Mesenteric Artery Disease
- Peripheral Artery Disease
- Thoracic Aortic Aneurysm
- Thoracic Outlet Syndrome
Biography
Shant Vartanian, M.D. is an assistant professor in the Division of Vascular and Endovascular Surgery. He has been with UCSF since 2003, completing his residency in General Surgery and a fellowship in Vascular Surgery.
He has played a leading role in the revitalization of the Vascular Surgery program at ZSFG. The rapidly maturing program routinely handles aortic trauma, complex endovascular interventions and is a busy clinical practice offering care for peripheral vascular and venous disorders for San Francisco Health Network (SFHN) patients. Dr. Vartanian started and is the medical director of the Vascular Lab, which performs over 1200 non-invasive diagnostic studies for the ZSFG community annually. His clinical research is focused on comparative effectiveness, quality improvement for dialysis access and innovations in dialysis access delivery.
Research Overview
Dr. Vartanian is interested in comparing the effectiveness of endovascular treatments for peripheral arterial disease. By understanding the safety, effectiveness, and cost of each intervention, the aim of the research is to assist patients and clinicians in making informed decisions about treatment options.
Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
- Study ID: NCT04514861Start Date: Aug 2020Estimated Completion Date: Dec 2021Condition(s): Peripheral Arterial Disease
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 41
Data provided by UCSF Profiles, powered by CTSI
- Moyer J, Wilson MW, Sorrentino TA, Santandreu A, Chen C, Hu D, Kerdok A, Porock E, Wright N, Ly J, Blaha C, Frassetto LA, Fissell WH, Vartanian SM, Roy S. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers. Toxins (Basel). 2023 09 04; 15(9). View in PubMed
- Kim EJ, Chen C, Gologorsky R, Santandreu A, Torres A, Wright N, Goodin MS, Moyer J, Chui BW, Blaha C, Brakeman P, Vartanian S, Tang Q, David Humes H, Fissell WH, Roy S. Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes. Nat Commun. 2023 08 29; 14(1):4890. View in PubMed
- Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes. PLoS One. 2023; 18(2):e0281371. View in PubMed
- Liu IH, El Khoury R, Wu B, Gasper WJ, Schneider PA, Hiramoto JS, Vartanian SM, Conte MS. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia. J Vasc Surg. 2023 04; 77(4):1137-1146.e3. View in PubMed
- Santandreu AG, Taheri-Tehrani P, Feinberg B, Torres A, Blaha C, Shaheen R, Moyer J, Wright N, Szot GL, Fissell WH, Vartanian S, Posselt A, Roy S. Characterization of human islet function in a convection-driven intravascular bioartificial pancreas. Bioeng Transl Med. 2023 Mar; 8(2):e10444. View in PubMed
- View All Publications
In the News
- UCSF Surgical Innovations Program - - October 05, 2017At the heart of the UC Berkeley-UCSF Master of Translational Medicine (MTM) program is a hands-on capstone project, where student teams work on developing medical technologies from idea to bedside. Three Surgical Innovations Accelerator projects from the Spring 2017 cycle have been selected to participate in the program this year: Percutaneous AV Fistula, Tracheostomy Alarm, and Augmented Surgical Vision, adding to a lengthy list of Surgical Innovations (SI) projects that have hosted MTM [...]
- UCSF Surgical Innovations Program - - April 24, 2017Six UCSF faculty pitched their medical device ideas to a panel of industry experts for the chance to win seed funding, engineering support, and product development advising at the Surgical Innovations Shark Tank on Tuesday, April 4, 2017 at UCSF's Mission Bay campus. This was the 2nd Shark Tank hosted by Surgical Innovations, an internal incubator/accelerator for early-stage medical devices ideas, and the first to be open to faculty in all UCSF schools and departments. The initiative was [...]
- UCSF Division of Vascular Surgery - - April 24, 2017Shant Vartanian, M.D. received an Accelerator Award to develop a Percutaneous Arteriovenous Fistula Device for Dialysis Access at the Surgical Innovations Shark Tank on Tuesday, April 4, 2017 at UCSF's Mission Bay campus. This was the 2nd Shark Tank hosted by Surgical Innovations, an internal incubator/accelerator for early-stage medical devices ideas, and the first to be open to faculty in all UCSF schools and departments. The initiative was launched 3 years ago by the Department of Surgery [...]